DOC

Aromasin Reduced Breast Cancer Risk in Postmenopausal Women

By Raymond Peterson,2014-10-10 21:42
16 views 0
The anti-estrogen drug Aromasin appears to cut the odds of breast cancer by 65 percent in high-risk postmenopausal women, new research has found
null
null
null

Report this document

For any questions or suggestions please email
cust-service@docsford.com